Skip to main content
Erschienen in: Herz 1/2020

17.05.2018 | Original articles

Endothelial dysfunction following coronary artery bypass grafting

Influence of patient and procedural factors

verfasst von: PD Dr. J. Hadem, R. Rossnick, B. Hesse, M. Herr, M. Hansen, A. Bergmann, G. Kensah, C. Maess, H. Baraki, P. Kümpers, A. Lukasz, I. Kutschka

Erschienen in: Herz | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Angiopoietin-2 (Angpt2) mediates endothelial dysfunction (ED) following coronary artery bypass grafting (CABG). Its triggers are, however, poorly understood.

Methods

We examined the time course of ED beyond the early phase of postoperative recovery in 75 patients following CABG with a special focus on different cardiopulmonary bypass (CPB) modes as potential triggers of Angpt2 release.

Results

Nine patients (12.0%) underwent off-pump coronary artery bypass (OPCAB), 31 patients (41.3%) received minimized extracorporeal circulation (MECC), and 35 patients (46.6%) were operated on with (conventional) CPB. Angpt2 levels steadily increased across the observation period (1.7 [1.4–2.1] to 3.4 [2.5–6.1] ng/ml, p < 0.001). Angpt2 levels did not differ between the MECC and CPB groups (p = 0.564). There was no difference between MECC and CPB patients regarding net fluid balance (p = 0.821) and other surrogate markers of postoperative ED. The magnitude of Angpt-2 increase correlated more strongly with baseline C‑reactive protein (r = 0.459, p < 0.001) than with any other parameter. Hospital length of stay correlated more strongly with baseline Angpt2 levels (r = 0.512, p = 0.005) than with follow-up Angpt2 levels and appeared not to be influenced by CPB mode (p = 0.428).

Conclusion

CABG is associated with prolonged ED, which is determined by the patient’s preoperative inflammatory state rather than by CPB modifications.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Augustin HG, Koh GY, Thurston G et al (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10:165–177CrossRef Augustin HG, Koh GY, Thurston G et al (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10:165–177CrossRef
2.
Zurück zum Zitat Fiedler U, Reiss Y, Scharpfenecker M et al (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12:235–239CrossRef Fiedler U, Reiss Y, Scharpfenecker M et al (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12:235–239CrossRef
3.
Zurück zum Zitat Fiedler U, Scharpfenecker M, Koidl S et al (2004) The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103:4150–4156CrossRef Fiedler U, Scharpfenecker M, Koidl S et al (2004) The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103:4150–4156CrossRef
4.
Zurück zum Zitat Fiedler U, Krissl T, Koidl S et al (2003) Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem 278:1721–1727CrossRef Fiedler U, Krissl T, Koidl S et al (2003) Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem 278:1721–1727CrossRef
5.
Zurück zum Zitat Parikh SM, Mammoto T, Schultz A et al (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. Plos Med 3:356–370CrossRef Parikh SM, Mammoto T, Schultz A et al (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. Plos Med 3:356–370CrossRef
6.
Zurück zum Zitat Roviezzo F, Tsigkos S, Kotanidou A et al (2005) Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 314:738–744CrossRef Roviezzo F, Tsigkos S, Kotanidou A et al (2005) Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 314:738–744CrossRef
7.
Zurück zum Zitat Kümpers P, Lukasz A, David S et al (2008) Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 12:R147CrossRef Kümpers P, Lukasz A, David S et al (2008) Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 12:R147CrossRef
8.
Zurück zum Zitat Kümpers P, Hafer C, David S et al (2010) Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 36:462–470CrossRef Kümpers P, Hafer C, David S et al (2010) Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 36:462–470CrossRef
9.
Zurück zum Zitat Hadem J, Bockmeyer CL, Lukasz A et al (2012) Angiopoietin-2 in acute liver failure. Crit Care Med 40:1499–1505CrossRef Hadem J, Bockmeyer CL, Lukasz A et al (2012) Angiopoietin-2 in acute liver failure. Crit Care Med 40:1499–1505CrossRef
10.
Zurück zum Zitat Clajus C, Lukasz A, David S et al (2012) Angiopoietin- is a potential mediator of endothelial barrir dysfunction following cardiopulmonary bypass. Cytokine 60:352–359CrossRef Clajus C, Lukasz A, David S et al (2012) Angiopoietin- is a potential mediator of endothelial barrir dysfunction following cardiopulmonary bypass. Cytokine 60:352–359CrossRef
11.
Zurück zum Zitat Brettner F, Chappell D, Schwartz L et al (2017) Vascular endothelial dysfunction during cardiac surgery: on-pump versus off-pump coronary surgery. Eur Surg Res 58:354–368CrossRef Brettner F, Chappell D, Schwartz L et al (2017) Vascular endothelial dysfunction during cardiac surgery: on-pump versus off-pump coronary surgery. Eur Surg Res 58:354–368CrossRef
12.
Zurück zum Zitat Puehler T, Haneya A, Philipp A et al (2009) Minimal extracorporeal circulation: an alternative for on-pump and off-pump coronary revascularization. Ann Thorac Surg 87:766–772CrossRef Puehler T, Haneya A, Philipp A et al (2009) Minimal extracorporeal circulation: an alternative for on-pump and off-pump coronary revascularization. Ann Thorac Surg 87:766–772CrossRef
13.
Zurück zum Zitat El-Essawi A, Hajek T, Skorpil J et al (2011) Are minimized perfusion circuits the better heart lung machines? Final results of a prospective randomized multicentre trial. Perfusion 26:470–478CrossRef El-Essawi A, Hajek T, Skorpil J et al (2011) Are minimized perfusion circuits the better heart lung machines? Final results of a prospective randomized multicentre trial. Perfusion 26:470–478CrossRef
14.
Zurück zum Zitat Kutschka I, Skorpil J, El Essawi A et al (2009) Beneficial effects of modern perfusion concepts in aortic valve and aortic root surgery. Perfusion 24:37–44CrossRef Kutschka I, Skorpil J, El Essawi A et al (2009) Beneficial effects of modern perfusion concepts in aortic valve and aortic root surgery. Perfusion 24:37–44CrossRef
15.
Zurück zum Zitat Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRef Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRef
16.
Zurück zum Zitat WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO technical report series 894. World Health Organization, Geneva WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO technical report series 894. World Health Organization, Geneva
17.
Zurück zum Zitat Jongman RM, van Klarenbosch J, Molema G et al (2015) Angiopoietin/Tie2 dysbalance is associated with acute kidney injury after cardiac surgery assisted by cardiopulmonary bypass. PLoS ONE 10:e136205CrossRef Jongman RM, van Klarenbosch J, Molema G et al (2015) Angiopoietin/Tie2 dysbalance is associated with acute kidney injury after cardiac surgery assisted by cardiopulmonary bypass. PLoS ONE 10:e136205CrossRef
18.
Zurück zum Zitat Charbonney E, Wilcox E, Shan Y et al (2017) Systemic angiopoietin-1/2 dysregulation following cardiopulmonay bypass in adults. Future Sci Oa 3:FSO166CrossRef Charbonney E, Wilcox E, Shan Y et al (2017) Systemic angiopoietin-1/2 dysregulation following cardiopulmonay bypass in adults. Future Sci Oa 3:FSO166CrossRef
19.
Zurück zum Zitat Jongman RM, Zijlstra JG, Ko KWF et al (2014) Off-pump CABG surgery reduces systemic inflammation compared with on-pump surgery but does not change systemic endothelial responses: a prospective randomized study. Shock 42:121–128CrossRef Jongman RM, Zijlstra JG, Ko KWF et al (2014) Off-pump CABG surgery reduces systemic inflammation compared with on-pump surgery but does not change systemic endothelial responses: a prospective randomized study. Shock 42:121–128CrossRef
20.
Zurück zum Zitat Lamy A, Devereaux PJ, Prabhakaran D et al (2016) Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting. N Engl J Med 375:2359–2368CrossRef Lamy A, Devereaux PJ, Prabhakaran D et al (2016) Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting. N Engl J Med 375:2359–2368CrossRef
21.
Zurück zum Zitat Shroyer AL, Grover FL, Hattler B et al (2009) On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 361:1827–1837CrossRef Shroyer AL, Grover FL, Hattler B et al (2009) On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 361:1827–1837CrossRef
22.
Zurück zum Zitat Selnes OA, Gottesmann RF, Grega MA et al (2012) Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med 366:250–257CrossRef Selnes OA, Gottesmann RF, Grega MA et al (2012) Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med 366:250–257CrossRef
23.
Zurück zum Zitat Selnes OA, Grega MA, Baily MM et al (2009) Do management strategies for coronary artery disease influence 6‑year cognitive outcomes? Ann Thorac Surg 88:445–454CrossRef Selnes OA, Grega MA, Baily MM et al (2009) Do management strategies for coronary artery disease influence 6‑year cognitive outcomes? Ann Thorac Surg 88:445–454CrossRef
Metadaten
Titel
Endothelial dysfunction following coronary artery bypass grafting
Influence of patient and procedural factors
verfasst von
PD Dr. J. Hadem
R. Rossnick
B. Hesse
M. Herr
M. Hansen
A. Bergmann
G. Kensah
C. Maess
H. Baraki
P. Kümpers
A. Lukasz
I. Kutschka
Publikationsdatum
17.05.2018
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 1/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-018-4708-0

Weitere Artikel der Ausgabe 1/2020

Herz 1/2020 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.